Management of Mouth Ulcers

First-Line Treatments

Gelclair mucoprotectant gel applied three times daily forms a protective coating over ulcerated surfaces, reducing pain and promoting healing 1, 2, 3
White soft paraffin ointment should be applied to the lips every 2 hours if they are affected by ulcers 2, 4
Betamethasone sodium phosphate 0.5 mg dissolved in 10 mL water as a 3-minute rinse-and-spit preparation four times daily 2, 3
For localized ulcers, clobetasol propionate 0.05% mixed in equal amounts with Orabase can be applied directly to the affected areas daily 2, 3

Benzydamine hydrochloride oral rinse or spray should be used every 3 hours, particularly before eating 2, 5
For more severe pain, topical anesthetic preparations such as viscous lidocaine 2% can be applied up to 3-4 times daily 2

Clean the mouth daily with warm saline mouthwashes to reduce bacterial colonization 2, 4
Use antiseptic oral rinses twice daily, such as 1.5% hydrogen peroxide mouthwash or 0.2% chlorhexidine digluconate mouthwash 2

If candidal infection is suspected, treat with Nystatin oral suspension 100,000 units four times daily for 1 week 2, 3
If candidal infection is suspected, treat with Miconazole oral gel 5-10 mL held in the mouth after food four times daily for 1 week 2, 3

Tacrolimus 0.1% ointment applied twice daily for 4 weeks 4
Intralesional triamcinolone injections in conjunction with topical clobetasol 3, 4
Systemic corticosteroids for highly symptomatic or recurrent ulcers 3, 4

Ensure proper diagnosis of the type of mouth ulcer before initiating treatment 4
For patients with recurrent aphthous ulcers, consider underlying systemic conditions that may require additional treatment 4

Betamethasone sodium phosphate 0.5 mg dissolved in 10 mL water is classified as a high‑potency topical corticosteroid when employed as a rinse‑and‑spit preparation for oral ulcers. 6
Hydrocortisone is classified as a low‑potency corticosteroid across all formulation types. [7][8]

Betamethasone‑based compounds (including dipropionate and valerate) achieve approximately 94 % good‑to‑excellent clinical response rates in inflammatory conditions, indicating strong therapeutic effectiveness. 9
In comparative trials, hydrocortisone (e.g., enemas or foam preparations delivering 100 mg/day) is used as a standard low‑potency option but requires a longer treatment duration to reach outcomes comparable to betamethasone. [7][8]

Topical oral application of betamethasone delivers potent anti‑inflammatory effects with minimal systemic absorption, supporting its safety for short‑term use in the oral cavity. 6
Both betamethasone and hydrocortisone carry a low and comparable risk of secondary candidal infection when used appropriately in the mouth. 6